Picture of VivoSim Labs logo

VIVS — VivoSim Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results

Dec 6 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO PROVIDES TIMING FOR RELEASE OF FXR314 PHASE 2
NASH
RESULTS
    * ORGANOVO HOLDINGS INC - RELEASE FINAL AND COMPLETE DATA
FROM A
PHASE 2A TRIAL OF FXR314 IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
PATIENTS BY APRIL 2024

Source text for Eikon:  ID:nGNX1SdJRQ 
Further company coverage:  ONVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on VivoSim Labs

See all news